- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00294606
Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Artery Surgery
February 17, 2006 updated by: Lawson Health Research Institute
Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Cross-Clamping During Carotid Endarterectomy Under General Anesthesia
This will be a prospective, randomized, double-blinded, cross-over clinical trial to compare the effects of phenylephrine or norepinephrine on cardiac function during carotid artery surgery in patients under general anesthesia.
The effect of the vasopressor on cardiac function will be measured using electrocardiography, transesophageal echocardiography and cardiac troponin I intraoperatively and postoperatively.
We will use a cross-over pattern since both drugs exhibit rapid onset and short duration of action.
We hypothesize that there will be less myocardial ischemia associated with the use of norepinephrine when compared with phenylephrine during carotid artery surgery.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- Recruiting
- University Hospital, LHSC
-
Contact:
- Rosemary A Craen, MD, FRCPC
- Phone Number: (519) 663-3022
- Email: Rosemary.Craen@lhsc.on.ca
-
Principal Investigator:
- Rosemary A Craen, MD, FRCPC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elective carotid endarterectomy under general anesthesia
- > 18 years old
- Written informed consent
Exclusion Criteria:
- Contraindication to general anesthesia
- Contraindication to transesophageal anesthesia
- esophageal disease
- esophageal stricture
- history of esophageal or gastric bleeding
- esophageal anatomic abnormality
- past esophageal or gastric surgery
- severe dysphagia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Myocardial ischemia measures by transesophageal echocardiography and ST segment analyses
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Myocardial ischemia measures by cardiac troponin I
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rosemary A Craen, MD, FRCPC, Associate Professor University of Western Ontario
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2006
Study Completion
February 1, 2006
Study Registration Dates
First Submitted
February 17, 2006
First Submitted That Met QC Criteria
February 17, 2006
First Posted (Estimate)
February 22, 2006
Study Record Updates
Last Update Posted (Estimate)
February 22, 2006
Last Update Submitted That Met QC Criteria
February 17, 2006
Last Verified
February 1, 2006
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Protective Agents
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Cardiotonic Agents
- Respiratory System Agents
- Sympathomimetics
- Vasoconstrictor Agents
- Mydriatics
- Nasal Decongestants
- Adrenergic alpha-1 Receptor Agonists
- Norepinephrine
- Phenylephrine
- Oxymetazoline
Other Study ID Numbers
- R-05-941
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.